Provera
Provera

0.43
A generic medicine indicated for women's health and hormonal conditions. Supports cyclic hormonal regulation to address irregular uterine cycles and related conditions.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Medroxyprogesterone acetate
Reference Brand
Medroxyprogesterone
Product Origin
Generic Alternative
Reference Manufacturer
Pfizer
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones, Menopause & HRT, Hormone Therapy
Product Category
Progestin
Pharmacological Class
Progesterone Derivative
Manufacturer Description
Designed to support uterine safety to manage menstrual flow and alleviate risk of endometrial hyperplasia.
Mechanism of Action
Inhibits pituitary gonadotropin release, preventing follicular maturation and stabilizing the endometrial tissue matrix.
Route of Administration
Oral
Onset Time
2–4 days
Duration
24 hours
Contraindications
History of deep vein thrombosis, Breast cancer, Unexplained vaginal bleeding, Pregnancy
Severe Adverse Events
Deep vein thrombosis — requires immediate medical attention, Pulmonary embolism — requires immediate medical attention
Common Side Effects
Weight changes, Headache, Breast tenderness
Uncommon Side Effects
Fluid retention, Mood changes, Irregular cycle bleeding
Drug Interactions
Rifampin, Ketoconazole
Pregnancy Safety Warnings
TGA Category X: Highly contraindicated. Avoid during pregnancy. Breastfeeding: Expelled in low amounts.
Age Restrictions
Approved for adult females.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Provera is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Antiviral Hepatitis Australia - Sofosbuvir Velpatasvir Hepatitis C Treatment